相似文献
1
Drug-Induced Liver Injury by Selective Androgenic Receptor Modulators.
Hepatol Commun. 2020 Jan 3;4(3):450-452. doi: 10.1002/hep4.1456. eCollection 2020 Mar.
2
Selective Androgen Receptor Modulators: An Emerging Liver Toxin.
J Clin Transl Hepatol. 2023 Feb 28;11(1):188-196. doi: 10.14218/JCTH.2022.00207. Epub 2022 Nov 4.
3
Comparative safety evaluation of selective androgen receptor modulators and anabolic androgenic steroids.
Expert Opin Drug Saf. 2015;14(11):1773-85. doi: 10.1517/14740338.2015.1094052. Epub 2015 Sep 24.
4
Selective Androgen Receptor Modulators: Current Knowledge and Clinical Applications.
Sex Med Rev. 2019 Jan;7(1):84-94. doi: 10.1016/j.sxmr.2018.09.006. Epub 2018 Nov 30.
5
Selective Androgen Receptor Modulator-Induced Liver Injury in Active Duty Male.
Mil Med. 2023 Jul 22;188(7-8). doi: 10.1093/milmed/usac039. Epub 2022 Mar 7.
6
Novel Uses for the Anabolic Androgenic Steroids Nandrolone and Oxandrolone in the Management of Male Health.
Curr Urol Rep. 2016 Oct;17(10):72. doi: 10.1007/s11934-016-0629-8.
7
Drug-Induced Liver Injury From Enobosarm (Ostarine), a Selective Androgen Receptor Modulator.
ACG Case Rep J. 2021 Jan 7;8(1):e00518. doi: 10.14309/crj.0000000000000518. eCollection 2021 Jan.
8
Pharmacodynamics of selective androgen receptor modulators.
J Pharmacol Exp Ther. 2003 Mar;304(3):1334-40. doi: 10.1124/jpet.102.040840.
9
Profiling of anabolic androgenic steroids and selective androgen receptor modulators for interference with adrenal steroidogenesis.
Biochem Pharmacol. 2020 Feb;172:113781. doi: 10.1016/j.bcp.2019.113781. Epub 2019 Dec 27.
10
Selective androgen receptor modulators: the future of androgen therapy?
Transl Androl Urol. 2020 Mar;9(Suppl 2):S135-S148. doi: 10.21037/tau.2019.11.02.
引用本文的文献
1
The Potential of SARMs and Antimyostatin Agents in Addressing Lean Body Mass Loss From GLP-1 Agonists: A Literature Review.
J Diabetes. 2025 Aug;17(8):e70119. doi: 10.1111/1753-0407.70119.
2
Silent Threats to the Liver: Acute Hepatotoxicity Attributed to Selective Androgen Receptor Modulators (SARMs).
Cureus. 2025 Jun 7;17(6):e85500. doi: 10.7759/cureus.85500. eCollection 2025 Jun.
3
Ligandrol lowers endurance and negatively affects lipid and hormonal profile of male rats.
Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar 15. doi: 10.1007/s00210-025-04028-8.
4
Abuse of Anabolic-Androgenic Steroids as a Social Phenomenon and Medical Problem-Its Potential Negative Impact on Reproductive Health Based on 50 Years of Case Report Analysis.
J Clin Med. 2024 Oct 2;13(19):5892. doi: 10.3390/jcm13195892.
5
Illegal Use of Testosterone and Other Anabolic-Androgenic Steroids in the Population of Amateur Athletes in Wrocław, Poland-An Unfavorable Lifestyle Trend in the Population of Men of Reproductive Age.
J Clin Med. 2024 Jun 26;13(13):3719. doi: 10.3390/jcm13133719.
6
Ostarine blunts the effect of endurance training on submaximal endurance in rats.
Naunyn Schmiedebergs Arch Pharmacol. 2024 Sep;397(9):6523-6532. doi: 10.1007/s00210-024-03030-w. Epub 2024 Mar 7.
7
Severe liver injury following use of RAD-140, a selective androgen receptor modulator, for body building.
Aust Prescr. 2024 Feb;47(1):26-28. doi: 10.18773/austprescr.2024.004.
8
Selective androgen receptor modulator use and related adverse events including drug-induced liver injury: Analysis of suspected cases.
Eur J Clin Pharmacol. 2024 Feb;80(2):185-202. doi: 10.1007/s00228-023-03592-3. Epub 2023 Dec 7.
9
Androgen Receptor and Cardiovascular Disease: A Potential Risk for the Abuse of Supplements Containing Selective Androgen Receptor Modulators.
Nutrients. 2023 Jul 26;15(15):3330. doi: 10.3390/nu15153330.
10
Systematic Review of Safety of Selective Androgen Receptor Modulators in Healthy Adults: Implications for Recreational Users.
J Xenobiot. 2023 May 10;13(2):218-236. doi: 10.3390/jox13020017.
本文引用的文献
1
Safety, Pharmacokinetic, and Pharmacodynamic Evaluation After Single and Multiple Ascending Doses of a Novel Selective Androgen Receptor Modulator in Healthy Subjects.
Clin Ther. 2016 Jun;38(6):1401-1416. doi: 10.1016/j.clinthera.2016.03.025. Epub 2016 Apr 13.
2
Causality assessment for suspected DILI during clinical phases of drug development.
Drug Saf. 2014 Nov;37 Suppl 1(Suppl 1):S47-56. doi: 10.1007/s40264-014-0185-4.
3
ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury.
Am J Gastroenterol. 2014 Jul;109(7):950-66; quiz 967. doi: 10.1038/ajg.2014.131. Epub 2014 Jun 17.
4
Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial.
Lancet Oncol. 2013 Apr;14(4):335-45. doi: 10.1016/S1470-2045(13)70055-X. Epub 2013 Mar 14.
5
The safety, pharmacokinetics, and effects of LGD-4033, a novel nonsteroidal oral, selective androgen receptor modulator, in healthy young men.
J Gerontol A Biol Sci Med Sci. 2013 Jan;68(1):87-95. doi: 10.1093/gerona/gls078. Epub 2012 Mar 28.
6
The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial.
J Cachexia Sarcopenia Muscle. 2011 Sep;2(3):153-161. doi: 10.1007/s13539-011-0034-6. Epub 2011 Aug 2.
Zotero 插件